COPS5 and colorectal adenocarcinoma: Data downloaded from cBioportal shows that 41.4, 22.9, and 20.7% genetic alterations of Jab1/COPS5 have been recorded in neuroendocrine prostate cancer (NEPC), colorectal adenocarcinoma triplets (MSKCC) and breast cancer, respectively.